Humulin 70/30 Kwik Pen (Insulin PFS) 100 units/ml-3ml

Humulin 70/30 Kwik Pen is an antidiabetic medication used to manage blood glucose levels in patients with diabetes mellitus.

• Type 1 diabetes mellitus: Helps manage blood glucose levels in patients who require insulin.
• Type 2 diabetes mellitus: Used in combination with diet and exercise to control blood sugar levels.
• Gestational diabetes: May be used to manage blood glucose levels during pregnancy under medical supervision.

• Humulin 70/30 Kwik Pen works by activating insulin receptors, which increases cellular glucose uptake and utilization, thereby lowering blood glucose levels. It combines intermediate-acting (NPH) and short-acting (regular) insulin to provide both immediate and prolonged glucose control.

Humulin 70/30 Kwik Pen may cause various side effects, ranging from common to serious.

Common Side Effects

• Injection site reactions: Redness, swelling, or itching at the injection site.
• Hypoglycemia: Low blood sugar levels, which may cause dizziness, sweating, and confusion.
• Weight gain: Increased body weight due to improved glucose control.
• Lipodystrophy: Changes in fat tissue at injection sites.

Serious or Rare Side Effects

• Severe hypoglycemia: Life-threatening low blood sugar requiring immediate medical attention.
• Hypersensitivity reactions: Allergic reactions including rash, itching, and difficulty breathing.
• Peripheral edema: Swelling in the extremities due to fluid retention.
• Cardiovascular events: Increased risk of heart disease in some patients.

Humulin 70/30 Kwik Pen should be used with caution and under medical supervision.

• Dosage adjustment: Regular monitoring of blood glucose levels is essential to adjust the dosage as needed.
• Hypoglycemia management: Patients should be educated on recognizing and treating hypoglycemia.
• Injection technique: Proper injection technique should be followed to avoid injection site reactions.
• Pregnancy and breastfeeding: Use during pregnancy and breastfeeding should be discussed with a healthcare provider.
• Storage: Store at room temperature up to 86°F (30°C): Keep away from heat and light. Throw away the pen after 10 days, even if it still has insulin left in it.

Humulin 70/30 Kwik Pen may interact with other medications, affecting its efficacy or increasing the risk of side effects.

Major Interactions (Avoid)

• Oral antidiabetic agents: May enhance the hypoglycemic effect, increasing the risk of low blood sugar.
• Insulin secretagogues: May cause severe hypoglycemia when used together.
• Monoamine oxidase inhibitors: Can potentiate the hypoglycemic effect of insulin.

Moderate Interactions (Monitor Closely)

• Beta-blockers: May mask the symptoms of hypoglycemia.
• Corticosteroids: Can reduce the effectiveness of insulin, requiring dosage adjustments.
• Thiazide diuretics: May increase blood glucose levels, necessitating insulin dose adjustments.